Alx Oncology Holdings Inc. (ALXO) NASDAQ
$16.22 0.72 (4.64%)
Market Cap: $775M
As of 04/24/24 04:00 PM EDT. Market closed.
Alx Oncology Holdings Inc. (ALXO)
NASDAQ
$16.22
0.72 (4.64%)
Market Cap: $775M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
alx oncology (previously alexo therapeutics) is a clinical-stage immuno-oncology company developing therapies that block the cd47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system. our lead candidate, alx148, is a fusion protein that comprises an engineered high affinity cd47 binding domain of sirpa linked to an inactive fc region of human immunoglobulin. alx148 is ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
57
Address
.
PRICE CHART FOR ALX ONCOLOGY HOLDINGS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.29
Previous Close
$15.50
Days Range
$15.24 - $16.25
52 week range
$3.94 - $17.42
Volume
441,585
Avg. Volume (30 days)
630,285
Market Cap
$775M
Dividend Yield
-
P/E
-
Shares Outstanding
50,000,000
Open
$15.29
Previous Close
$15.50
Days Range
$15.24 - $16.25
52 week range
$3.94 - $17.42
Volume
441,585
Avg. Volume (30 days)
630,285
Market Cap
$775M
Dividend Yield
-
P/E
-
Shares Outstanding
50,000,000
FINANCIAL STATEMENTS FOR ALX ONCOLOGY HOLDINGS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ALX ONCOLOGY HOLDINGS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Pons Jaume | PRESIDENT & CSO | Apr 16, 2024 | Option Exercise | $0.99 | 25,846 | 25,588 | 654,205 | Apr 18, 2024, 04:49 PM |
| Pons Jaume | PRESIDENT & CSO | Apr 16, 2024 | Sale | $14.20 | 50,000 | 710,195 | 604,205 | Apr 18, 2024, 04:49 PM |
| Pons Jaume | PRESIDENT & CSO | Apr 04, 2024 | Sale | $11.15 | 20,000 | 223,036 | 628,359 | Apr 05, 2024, 05:37 PM |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | Mar 14, 2024 | Buy | $11.31 | 4,400 | 49,771 | 171,620 | Mar 18, 2024, 04:06 PM |
| Pinto Shelly | SVP, Finance and CAO | Jan 04, 2024 | Sale | $13.60 | 2,717 | 36,957 | 78,591 | Jan 05, 2024, 04:03 PM |
| Pinto Shelly | SVP, Finance and CAO | Dec 29, 2023 | Sale | $15.04 | 1,631 | 24,530 | 81,308 | Jan 03, 2024, 04:28 PM |
| Randolph Sophia | Chief Medical Officer | Dec 29, 2023 | Sale | $15.04 | 3,128 | 47,045 | 312,349 | Jan 03, 2024, 04:25 PM |
| Pons Jaume | President & CSO | Dec 29, 2023 | Sale | $15.04 | 7,179 | 107,972 | 618,359 | Jan 03, 2024, 04:17 PM |
| Pinto Shelly | VP, Finance and CAO | Jul 06, 2023 | Sale | $6.52 | 7,345 | 47,889 | 55,713 | Jul 07, 2023, 04:09 PM |
| Randolph Sophia | Chief Medical Officer | Jun 30, 2023 | Sale | $7.34 | 1,605 | 11,781 | 281,477 | Jul 05, 2023, 05:09 PM |
| Pons Jaume | President & CEO | Jun 30, 2023 | Sale | $7.34 | 3,208 | 23,547 | 536,538 | Jul 05, 2023, 05:07 PM |
| Pinto Shelly | VP, Finance and CAO | Jun 30, 2023 | Sale | $7.34 | 466 | 3,420 | 63,058 | Jul 05, 2023, 05:05 PM |
| GARCIA PETER S | Chief Financial Officer | Jun 30, 2023 | Sale | $7.34 | 887 | 6,511 | 54,738 | Jul 05, 2023, 05:00 PM |
| Randolph Sophia | Chief Medical Officer | Jun 09, 2023 | Option Exercise | $3.75 | 12,829 | 48,171 | 283,082 | Jun 13, 2023, 04:38 PM |
| Pinto Shelly | VP, Finance and CAO | Dec 29, 2022 | Sale | $11.07 | 482 | 5,336 | 62,097 | Jan 03, 2023, 08:52 PM |
| Randolph Sophia | Chief Medical Officer | Dec 29, 2022 | Sale | $11.07 | 1,617 | 17,901 | 270,253 | Jan 03, 2023, 08:47 PM |
| GARCIA PETER S | Chief Financial Officer | Dec 29, 2022 | Sale | $11.07 | 893 | 9,886 | 53,723 | Jan 03, 2023, 08:34 PM |
| Pons Jaume | President & CEO | Dec 29, 2022 | Sale | $11.07 | 3,232 | 35,779 | 539,746 | Jan 03, 2023, 08:29 PM |
| Randolph Sophia | Chief Medical Officer | Dec 16, 2022 | Option Exercise | $4.09 | 46,474 | 189,875 | 271,870 | Dec 20, 2022, 05:08 PM |
| GARCIA PETER S | Chief Financial Officer | Feb 07, 2022 | Option Exercise | $4.49 | 15,000 | 67,305 | 24,483 | Feb 08, 2022, 08:23 PM |
| Pons Jaume | President & CEO | Feb 03, 2022 | Option Exercise | $1.46 | 24,154 | 35,186 | 468,978 | Feb 07, 2022, 08:27 AM |
| Randolph Sophia | Chief Medical Officer | Dec 15, 2021 | Option Exercise | $1.42 | 23,852 | 33,788 | 188,396 | Dec 16, 2021, 08:47 PM |
| Lettmann Jason | Director | Dec 13, 2021 | Sale | $27.36 | 325,377 | 8,901,804 | 2,127,969 | Dec 15, 2021, 09:48 PM |
| LSV Associates, LLC | 10% Owner | Dec 13, 2021 | Sale | $26.61 | 42,588 | 1,133,067 | 2,127,969 | Dec 15, 2021, 09:03 PM |
| LSV Associates, LLC | 10% Owner | Dec 13, 2021 | Sale | $26.61 | 5,802 | 154,365 | 290,131 | Dec 15, 2021, 09:03 PM |
| Lettmann Jason | Director | Dec 10, 2021 | Sale | $31.31 | 26,274 | 822,719 | 2,155,944 | Dec 10, 2021, 09:22 PM |
| Lettmann Jason | Director | Dec 09, 2021 | Sale | $32.03 | 76,905 | 2,463,502 | 2,219,268 | Dec 10, 2021, 09:22 PM |
| Lettmann Jason | Director | Dec 08, 2021 | Sale | $33.25 | 42,458 | 1,411,871 | 2,232,251 | Dec 10, 2021, 09:22 PM |
| LSV Associates, LLC | 10% Owner | Dec 09, 2021 | Sale | $32.03 | 67,683 | 2,168,093 | 2,219,268 | Dec 10, 2021, 07:51 PM |
| LSV Associates, LLC | 10% Owner | Dec 08, 2021 | Sale | $33.25 | 5,091 | 169,292 | 304,339 | Dec 10, 2021, 07:51 PM |
| LSV Associates, LLC | 10% Owner | Dec 08, 2021 | Sale | $33.25 | 37,367 | 1,242,578 | 2,232,251 | Dec 10, 2021, 07:51 PM |
| LSV Associates, LLC | 10% Owner | Dec 10, 2021 | Sale | $31.31 | 3,151 | 98,667 | 293,942 | Dec 10, 2021, 07:51 PM |
| LSV Associates, LLC | 10% Owner | Dec 10, 2021 | Sale | $31.31 | 23,123 | 724,052 | 2,155,944 | Dec 10, 2021, 07:51 PM |
| LSV Associates, LLC | 10% Owner | Dec 09, 2021 | Sale | $32.03 | 9,222 | 295,409 | 302,571 | Dec 10, 2021, 07:51 PM |
| Randolph Sophia | Chief Medical Officer | Nov 22, 2021 | Option Exercise | $4.08 | 30,000 | 122,400 | 179,428 | Nov 23, 2021, 04:29 PM |
| Randolph Sophia | Chief Medical Officer | Nov 22, 2021 | Sale | $36.77 | 14,884 | 547,314 | 164,544 | Nov 23, 2021, 04:29 PM |
| Pons Jaume | President & CEO | Oct 19, 2021 | Sale | $54.29 | 16,700 | 906,714 | 446,827 | Oct 20, 2021, 07:10 PM |
| Pons Jaume | President & CEO | Oct 19, 2021 | Sale | $54.29 | 16,700 | 906,714 | 446,827 | Oct 20, 2021, 07:09 PM |
| GARCIA PETER S | Chief Financial Officer | Oct 18, 2021 | Option Exercise | $4.08 | 7,229 | 29,494 | 16,560 | Oct 19, 2021, 04:28 PM |
| GARCIA PETER S | Chief Financial Officer | Oct 18, 2021 | Sale | $55.44 | 7,229 | 400,793 | 13,709 | Oct 19, 2021, 04:28 PM |
| Randolph Sophia | Chief Medical Officer | Oct 11, 2021 | Sale | $60.97 | 7,387 | 450,422 | 151,867 | Oct 12, 2021, 04:29 PM |
| Pons Jaume | President & CEO | Sep 20, 2021 | Sale | $74.38 | 16,700 | 1,242,213 | 473,569 | Sep 21, 2021, 04:17 PM |
| GARCIA PETER S | Chief Financial Officer | Sep 17, 2021 | Option Exercise | $4.08 | 11,345 | 46,288 | 20,676 | Sep 17, 2021, 08:45 PM |
| GARCIA PETER S | Chief Financial Officer | Sep 16, 2021 | Option Exercise | $4.08 | 1,426 | 5,818 | 10,757 | Sep 17, 2021, 08:45 PM |
| GARCIA PETER S | Chief Financial Officer | Sep 16, 2021 | Sale | $80.43 | 1,426 | 114,695 | 9,331 | Sep 17, 2021, 08:45 PM |
| GARCIA PETER S | Chief Financial Officer | Sep 17, 2021 | Sale | $78.96 | 11,345 | 895,811 | 19,649 | Sep 17, 2021, 08:45 PM |
| Randolph Sophia | Chief Medical Officer | Sep 10, 2021 | Sale | $77.66 | 7,387 | 573,670 | 163,302 | Sep 13, 2021, 07:10 PM |
| GARCIA PETER S | Chief Financial Officer | Aug 23, 2021 | Option Exercise | $4.08 | 60,000 | 244,800 | 69,331 | Aug 24, 2021, 06:17 PM |
| GARCIA PETER S | Chief Financial Officer | Aug 23, 2021 | Sale | $74.15 | 60,000 | 4,448,762 | 67,738 | Aug 24, 2021, 06:17 PM |
| Pons Jaume | President & CEO | Aug 19, 2021 | Sale | $61.28 | 16,700 | 1,023,340 | 487,065 | Aug 20, 2021, 08:07 PM |
| GARCIA PETER S | Chief Financial Officer | Aug 17, 2021 | Option Exercise | $4.08 | 10,000 | 40,800 | 19,331 | Aug 18, 2021, 07:11 PM |
| GARCIA PETER S | Chief Financial Officer | Aug 17, 2021 | Sale | $66.23 | 10,000 | 662,299 | 14,644 | Aug 18, 2021, 07:11 PM |
| Randolph Sophia | Chief Medical Officer | Aug 10, 2021 | Sale | $64.63 | 7,387 | 477,439 | 169,871 | Aug 11, 2021, 04:11 PM |
| Pons Jaume | President & CEO | Jul 19, 2021 | Sale | $54.57 | 16,700 | 911,245 | 509,946 | Jul 20, 2021, 04:12 PM |
| Randolph Sophia | Chief Medical Officer | Jul 12, 2021 | Sale | $54.90 | 7,387 | 405,527 | 171,889 | Jul 14, 2021, 04:50 PM |
| Pons Jaume | President & CEO | May 19, 2021 | Sale | $55.71 | 16,700 | 930,276 | 544,146 | May 20, 2021, 07:52 PM |
| Pons Jaume | President & CEO | Apr 19, 2021 | Sale | $57.63 | 16,700 | 962,433 | 556,016 | Apr 21, 2021, 04:14 PM |
| Randolph Sophia | Chief Medical Officer | Apr 12, 2021 | Sale | $59.43 | 7,387 | 438,978 | 198,234 | Apr 13, 2021, 04:05 PM |
| Pons Jaume | President & CEO | Mar 25, 2021 | Option Exercise | $0.99 | 10,000 | 9,900 | 561,346 | Mar 26, 2021, 09:39 PM |
| Pons Jaume | President and CEO | Mar 22, 2021 | Option Exercise | $1.91 | 16,700 | 31,897 | 568,046 | Mar 24, 2021, 04:05 PM |
| Pons Jaume | President and CEO | Mar 22, 2021 | Sale | $68.49 | 16,700 | 1,143,860 | 566,846 | Mar 24, 2021, 04:05 PM |
| Randolph Sophia | Chief Medical Officer | Mar 10, 2021 | Sale | $74.34 | 7,387 | 549,173 | 207,227 | Mar 12, 2021, 09:39 PM |
| GARCIA PETER S | Chief Financial Officer | Jan 28, 2021 | Option Exercise | $4.08 | 6,128 | 25,002 | 9,128 | Jan 29, 2021, 04:15 PM |
| Pons Jaume | President & CEO | Jan 26, 2021 | Option Exercise | $0.99 | 10,000 | 9,900 | 551,346 | Jan 28, 2021, 06:01 AM |
| Graham G. Walmsley | Director | Dec 14, 2020 | Buy | $76.00 | 20,000 | 1,520,000 | 995,000 | Dec 15, 2020, 07:07 PM |
| LSV Associates, LLC | 10% Owner | Jul 21, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 378,000 | Jul 22, 2020, 04:18 PM |
| Lettmann Jason | Director | Jul 21, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 378,000 | Jul 21, 2020, 09:31 PM |
| Adelman Robert J | 10% Owner | Jul 21, 2020 | Buy | $19.00 | 3,000 | 57,000 | 99,406 | Jul 21, 2020, 09:29 PM |
| Adelman Robert J | 10% Owner | Jul 21, 2020 | Buy | $19.00 | 850,000 | 16,150,000 | 5,268,325 | Jul 21, 2020, 09:29 PM |
| Vivo Capital IX, LLC | 10% Owner | Jul 21, 2020 | Buy | $19.00 | 975,000 | 18,525,000 | 789,474 | Jul 21, 2020, 08:25 PM |
| Graham G. Walmsley | Director | Jul 21, 2020 | Buy | $19.00 | 975,000 | 18,525,000 | 975,000 | Jul 21, 2020, 08:04 PM |
| Hemrajani Rekha | Director | Jul 21, 2020 | Buy | $19.00 | 3,000 | 57,000 | 3,000 | Jul 21, 2020, 08:03 PM |
| GOODMAN COREY S | Director | Jul 21, 2020 | Buy | $19.00 | 850,000 | 16,150,000 | 850,000 | Jul 21, 2020, 08:01 PM |
| Pietzke Steffen | VP Fin & Chief Acct Officer | Jul 21, 2020 | Buy | $19.00 | 3,000 | 57,000 | 3,000 | Jul 21, 2020, 07:59 PM |
| GARCIA PETER S | Chief Financial Officer | Jul 21, 2020 | Buy | $19.00 | 3,000 | 57,000 | 3,000 | Jul 21, 2020, 07:57 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Pons Jaume | PRESIDENT & CSO | 04/16/2024 | 25,588 |
| Pons Jaume | PRESIDENT & CSO | 04/16/2024 | 710,195 |
| Pons Jaume | PRESIDENT & CSO | 04/04/2024 | 223,036 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | 03/14/2024 | 49,771 |
| Pinto Shelly | SVP, Finance and CAO | 01/04/2024 | 36,957 |
| Pinto Shelly | SVP, Finance and CAO | 12/29/2023 | 24,530 |
| Randolph Sophia | Chief Medical Officer | 12/29/2023 | 47,045 |
| Pons Jaume | President & CSO | 12/29/2023 | 107,972 |
| Pinto Shelly | VP, Finance and CAO | 07/06/2023 | 47,889 |
| Randolph Sophia | Chief Medical Officer | 06/30/2023 | 11,781 |
| Pons Jaume | President & CEO | 06/30/2023 | 23,547 |
| Pinto Shelly | VP, Finance and CAO | 06/30/2023 | 3,420 |
| GARCIA PETER S | Chief Financial Officer | 06/30/2023 | 6,511 |
| Randolph Sophia | Chief Medical Officer | 06/09/2023 | 48,171 |
| Pinto Shelly | VP, Finance and CAO | 12/29/2022 | 5,336 |
| Randolph Sophia | Chief Medical Officer | 12/29/2022 | 17,901 |
| GARCIA PETER S | Chief Financial Officer | 12/29/2022 | 9,886 |
| Pons Jaume | President & CEO | 12/29/2022 | 35,779 |
| Randolph Sophia | Chief Medical Officer | 12/16/2022 | 189,875 |
| GARCIA PETER S | Chief Financial Officer | 02/07/2022 | 67,305 |
| Pons Jaume | President & CEO | 02/03/2022 | 35,186 |
| Randolph Sophia | Chief Medical Officer | 12/15/2021 | 33,788 |
| Lettmann Jason | Director | 12/13/2021 | 8,901,804 |
| LSV Associates, LLC | 10% Owner | 12/13/2021 | 1,133,067 |
| LSV Associates, LLC | 10% Owner | 12/13/2021 | 154,365 |
| Lettmann Jason | Director | 12/10/2021 | 822,719 |
| Lettmann Jason | Director | 12/09/2021 | 2,463,502 |
| Lettmann Jason | Director | 12/08/2021 | 1,411,871 |
| LSV Associates, LLC | 10% Owner | 12/09/2021 | 2,168,093 |
| LSV Associates, LLC | 10% Owner | 12/08/2021 | 169,292 |
| LSV Associates, LLC | 10% Owner | 12/08/2021 | 1,242,578 |
| LSV Associates, LLC | 10% Owner | 12/10/2021 | 98,667 |
| LSV Associates, LLC | 10% Owner | 12/10/2021 | 724,052 |
| LSV Associates, LLC | 10% Owner | 12/09/2021 | 295,409 |
| Randolph Sophia | Chief Medical Officer | 11/22/2021 | 122,400 |
| Randolph Sophia | Chief Medical Officer | 11/22/2021 | 547,314 |
| Pons Jaume | President & CEO | 10/19/2021 | 906,714 |
| Pons Jaume | President & CEO | 10/19/2021 | 906,714 |
| GARCIA PETER S | Chief Financial Officer | 10/18/2021 | 29,494 |
| GARCIA PETER S | Chief Financial Officer | 10/18/2021 | 400,793 |
| Randolph Sophia | Chief Medical Officer | 10/11/2021 | 450,422 |
| Pons Jaume | President & CEO | 09/20/2021 | 1,242,213 |
| GARCIA PETER S | Chief Financial Officer | 09/17/2021 | 46,288 |
| GARCIA PETER S | Chief Financial Officer | 09/16/2021 | 5,818 |
| GARCIA PETER S | Chief Financial Officer | 09/16/2021 | 114,695 |
| GARCIA PETER S | Chief Financial Officer | 09/17/2021 | 895,811 |
| Randolph Sophia | Chief Medical Officer | 09/10/2021 | 573,670 |
| GARCIA PETER S | Chief Financial Officer | 08/23/2021 | 244,800 |
| GARCIA PETER S | Chief Financial Officer | 08/23/2021 | 4,448,762 |
| Pons Jaume | President & CEO | 08/19/2021 | 1,023,340 |
| GARCIA PETER S | Chief Financial Officer | 08/17/2021 | 40,800 |
| GARCIA PETER S | Chief Financial Officer | 08/17/2021 | 662,299 |
| Randolph Sophia | Chief Medical Officer | 08/10/2021 | 477,439 |
| Pons Jaume | President & CEO | 07/19/2021 | 911,245 |
| Randolph Sophia | Chief Medical Officer | 07/12/2021 | 405,527 |
| Pons Jaume | President & CEO | 05/19/2021 | 930,276 |
| Pons Jaume | President & CEO | 04/19/2021 | 962,433 |
| Randolph Sophia | Chief Medical Officer | 04/12/2021 | 438,978 |
| Pons Jaume | President & CEO | 03/25/2021 | 9,900 |
| Pons Jaume | President and CEO | 03/22/2021 | 31,897 |
| Pons Jaume | President and CEO | 03/22/2021 | 1,143,860 |
| Randolph Sophia | Chief Medical Officer | 03/10/2021 | 549,173 |
| GARCIA PETER S | Chief Financial Officer | 01/28/2021 | 25,002 |
| Pons Jaume | President & CEO | 01/26/2021 | 9,900 |
| Graham G. Walmsley | Director | 12/14/2020 | 1,520,000 |
| LSV Associates, LLC | 10% Owner | 07/21/2020 | 7,600,000 |
| Lettmann Jason | Director | 07/21/2020 | 7,600,000 |
| Adelman Robert J | 10% Owner | 07/21/2020 | 57,000 |
| Adelman Robert J | 10% Owner | 07/21/2020 | 16,150,000 |
| Vivo Capital IX, LLC | 10% Owner | 07/21/2020 | 18,525,000 |
| Graham G. Walmsley | Director | 07/21/2020 | 18,525,000 |
| Hemrajani Rekha | Director | 07/21/2020 | 57,000 |
| GOODMAN COREY S | Director | 07/21/2020 | 16,150,000 |
| Pietzke Steffen | VP Fin & Chief Acct Officer | 07/21/2020 | 57,000 |
| GARCIA PETER S | Chief Financial Officer | 07/21/2020 | 57,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ALX ONCOLOGY HOLDINGS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| VIVO CAPITAL, LLC | 4,220,048 | 3.7% | No change | Other |
| ORBIMED ADVISORS LLC | 3,095,000 | 0.92% | 7.8% | Other |
| BLACKROCK INC. | 2,235,093 | 0.00085% | 21.27% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 585,034 | 0.00091% | 32.04% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 270,500 | 0.00623% | 27.29% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 160,000 | 0.00493% | New | Other |
| D. E. SHAW & CO., INC. | 50,178 | 0.00065% | 9.84% | Other |
CHANGE IN SHARES OUTSTANDING FOR ALX ONCOLOGY HOLDINGS INC
STOCK BUYBACKS FOR ALX ONCOLOGY HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
19.23%
1Q
06/30/2023
20.03%
2Q
03/31/2023
20.07%
3Q
12/31/2022
20.41%
4Q
09/30/2022
20.41%
5Q
06/30/2022
20.58%
6Q
03/31/2022
20.79%
7Q
12/31/2021
21.05%
8Q
09/30/2021
21.45%
9Q
06/30/2021
21.90%
10Q
03/31/2021
22.49%
11Q
09/30/2020
65.39%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALX ONCOLOGY HOLDINGS INC
LOADING...